World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
57
Citations
9800
World Ranking
14014
National Ranking
5913

Mitchell Ho publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Mitchell Ho sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 151 publications — 27th percentile

27% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Mitchell Ho D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Mitchell Ho sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 57 D-Index — 31st percentile

31% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Mitchell Ho is affiliated with the Center for Cancer Research in the United States and has a robust publication record in the fields of medicine, biochemistry, genetics, and molecular biology. Their research primarily focuses on oncology, immunology, and related biomedical disciplines.

The scientist's major areas of study include:

  • Oncology
  • Immunology
  • Radiology, Nuclear Medicine and Imaging
  • Molecular Biology
  • Infectious Diseases

Mitchell Ho's work spans several key research topics, notably in immune-based therapies and molecular mechanisms in cancer and infectious diseases. Their main topics of interest include:

  • CAR-T cell therapy research
  • Monoclonal and Polyclonal Antibodies Research
  • Immunotherapy and Immune Responses
  • Glycosylation and Glycoproteins Research
  • SARS-CoV-2 and COVID-19 Research
  • Neuroblastoma Research and Treatments
  • Immune Cell Function and Interaction

Mitchell Ho has authored multiple research articles, contributing to the scientific discourse on cancer and immunotherapy. Representative recent publications include:

  • Persistent Polyfunctional Chimeric Antigen Receptor T Cells That Target Glypican 3 Eliminate Orthotopic Hepatocellular Carcinomas in Mice, 2020, Gastroenterology
  • Cancer therapy with antibodies, 2024, Nature reviews. Cancer
  • COVID-19 antibody therapeutics tracker: a global online database of antibody therapeutics for the prevention and treatment of COVID-19, 2020, Antibody Therapeutics
  • Shed antigen-induced blocking effect on CAR-T cells targeting Glypican-3 in Hepatocellular Carcinoma, 2021, Journal for ImmunoTherapy of Cancer
  • The Role of Glypicans in Cancer Progression and Therapy, 2020, Journal of Histochemistry & Cytochemistry

The scientist frequently collaborates with a core group of researchers, enhancing interdisciplinary engagement. Frequent co-authors include:

  • Dan Li
  • Nan Li
  • Jessica Hong
  • Zhijian Duan
  • T. Jake Liang

Mitchell Ho's publications are often featured in specialized venues related to antibody therapeutics and cancer research. Key publication venues consist of:

  • Antibody Therapeutics
  • Cancer Research
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal for ImmunoTherapy of Cancer
  • Nature Communications

Best Publications

  • High-throughput 3D spheroid culture and drug testing using a 384 hanging drop array

    Yi Chung Tung;Yi Chung Tung;Amy Y. Hsiao;Steven G. Allen;Yu Suke Torisawa

  • Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors

    Jennifer A A Gubbels;Jennifer Belisle;Masanori Onda;Claudine Rancourt

  • Mesothelin targeted cancer immunotherapy.

    Raffit Hassan;Mitchell Ho

  • Glypican-3: a new target for cancer immunotherapy

    Mitchell Ho;Heungnam Kim

  • Role of sorafenib in the treatment of advanced hepatocellular carcinoma: An update.

    Angela Gauthier;Mitchell Ho

  • Isolation of anti-CD22 Fv with high affinity by Fv display on human cells.

    Mitchell Ho;Satoshi Nagata;Ira Pastan

  • A Phase I Clinical Trial of Single-Dose Intrapleural IFN-β Gene Transfer for Malignant Pleural Mesothelioma and Metastatic Pleural Effusions: High Rate of Antitumor Immune Responses

    Daniel H. Sterman;Adri Recio;Richard G. Carroll;Colin T. Gillespie

  • A Binding Domain on Mesothelin for CA125/MUC16

    Osamu Kaneko;Lucy Gong;Jingli Zhang;Johanna K. Hansen

  • Therapeutically targeting glypican-3 via a conformation-specific single-domain antibody in hepatocellular carcinoma

    Mingqian Feng;Wei Gao;Ruoqi Wang;Weizao Chen

  • Humoral Immune Response to Mesothelin in Mesothelioma and Ovarian Cancer Patients

    Mitchell Ho;Raffit Hassan;Jingli Zhang;Qing-cheng Wang

  • Mesothelin Expression in Human Lung Cancer

    Mitchell Ho;Tapan K. Bera;Mark C. Willingham;Masanori Onda

  • Inactivation of Wnt signaling by a human antibody that recognizes the heparan sulfate chains of glypican‐3 for liver cancer therapy

    Wei Gao;Heungnam Kim;Mingqian Feng;Yen Phung

  • New immunotoxins targeting CD123, a stem cell antigen on acute myeloid leukemia cells

    Xing Du;Mitchell Ho;Ira Pastan

  • The role of mesothelin in tumor progression and targeted therapy

    Zhewei Tang;Min Qian;Mitchell Ho

  • Immunotoxin targeting glypican-3 regresses liver cancer via dual inhibition of Wnt signalling and protein synthesis

    Wei Gao;Zhewei Tang;Yi-Fan Zhang;Mingqian Feng

  • In vitro antibody evolution targeting germline hot spots to increase activity of an anti-CD22 immunotoxin.

    Mitchell Ho;Robert J. Kreitman;Masanori Onda;Ira Pastan

  • Glypican-3 antibodies: A new therapeutic target for liver cancer

    Mingqian Feng;Mitchell Ho

  • Glypicans as Cancer Therapeutic Targets

    Nan Li;Wei Gao;Yi-Fan Zhang;Mitchell Ho

  • Megakaryocyte Potentiation Factor Cleaved from Mesothelin Precursor Is a Useful Tumor Marker in the Serum of Patients with Mesothelioma

    Masanori Onda;Satoshi Nagata;Mitchell Ho;Tapan K. Bera

  • Therapeutically targeting glypican-2 via single-domain antibody-based chimeric antigen receptors and immunotoxins in neuroblastoma

    Nan Li;Haiying Fu;Haiying Fu;Stephen M. Hewitt;Dimiter S. Dimitrov

Frequent Co-Authors

Ira Pastan
Ira Pastan Center for Cancer Research
Dimiter S. Dimitrov
Dimiter S. Dimitrov University of Pittsburgh
Tim F. Greten
Tim F. Greten National Institutes of Health
Peter L. Choyke
Peter L. Choyke National Institutes of Health
Stephen M. Hewitt
Stephen M. Hewitt National Institutes of Health
Robert J. Kreitman
Robert J. Kreitman National Cancer Institute
David J. FitzGerald
David J. FitzGerald MRC Laboratory of Molecular Biology
Shuichi Takayama
Shuichi Takayama Georgia Institute of Technology
Martin F. Flajnik
Martin F. Flajnik University of Maryland, Baltimore
Matthew D. Hall
Matthew D. Hall National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing Biology and Biochemistry opens doors to diverse online degree options and rewarding career paths. Students interested in healthcare often continue with specialized programs that build upon their undergraduate foundation.

For those in nursing, the best online rn to bsn programs allow registered nurses to advance their qualifications and enter more specialized clinical roles. A background in biochemistry is also valuable for students seeking a degree in healthcare management, opening up leadership opportunities in hospitals, labs, and medical organizations.

Mental health is another fast-growing area. Those with science backgrounds may opt for accelerated msn psychiatric np programs to become mental health nurse practitioners. Alternatively, the health and wellness sector offers further options, such as an accredited 2 year nutrition degree online, for students eager to become registered dietitians or nutritionists.

Exploring these related online degrees can help biology and biochemistry graduates shape meaningful, high-impact careers in healthcare, research, and wellness.

Best Scientists Citing Mitchell Ho

Trending Scientists

Recently Published Articles